These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23812723)

  • 41. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions.
    Singer CF; Kronsteiner N; Marton E; Kubista M; Cullen KJ; Hirtenlehner K; Seifert M; Kubista E
    Breast Cancer Res Treat; 2002 Mar; 72(1):69-77. PubMed ID: 12000221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties.
    Imai K; Yokohama Y; Nakanishi I; Ohuchi E; Fujii Y; Nakai N; Okada Y
    J Biol Chem; 1995 Mar; 270(12):6691-7. PubMed ID: 7896811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
    Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
    Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
    Tang D; Piao Y; Zhao S; Mu X; Li S; Ma W; Song Y; Wang J; Zhao W; Zhang Q
    Med Oncol; 2014 Jul; 31(7):26. PubMed ID: 24861922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
    Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix metalloproteinases 2, 7, and 9 in tumors and sera of patients with breast cancer.
    Katunina AI; Gershtein ES; Ermilova VD; Tereshkina IV; Nazarenko AY; Tyleuova AA; Dvorova EK; Karabekova ZK; Gritskevich MV; Berezov TT
    Bull Exp Biol Med; 2011 Jul; 151(3):359-62. PubMed ID: 22451887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
    Jobim FC; Xavier NL; Uchoa DM; Cruz DB; Saciloto M; Chemello N; Schwartsmann G
    Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gelatinase levels in male and female breast cancer.
    Giannelli G; Fransvea E; Marinosci F; Bergamini C; Daniele A; Colucci S; Paradiso A; Quaranta M; Antonaci S
    Biochem Biophys Res Commun; 2002 Mar; 292(1):161-6. PubMed ID: 11890687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
    Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.
    Jinga DC; Blidaru A; Condrea I; Ardeleanu C; Dragomir C; Szegli G; Stefanescu M; Matache C
    J Cell Mol Med; 2006; 10(2):499-510. PubMed ID: 16796815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.
    Remacle AG; Noël A; Duggan C; McDermott E; O'Higgins N; Foidart JM; Duffy MJ
    Br J Cancer; 1998 Mar; 77(6):926-31. PubMed ID: 9528836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage.
    Ulmer TA; Keeler V; André S; Gabius HJ; Loh L; Laferté S
    Biochim Biophys Acta; 2010 Mar; 1800(3):336-43. PubMed ID: 19665518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
    Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
    FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis.
    Waas ET; Wobbes T; Lomme RM; DeGroot J; Ruers T; Hendriks T
    Br J Surg; 2003 Dec; 90(12):1556-64. PubMed ID: 14648736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer.
    Bogusiewicz M; Stryjecka-Zimmer M; Szymanski M; Rechberger T; Golabek W
    Otolaryngol Head Neck Surg; 2003 Jan; 128(1):132-6. PubMed ID: 12574771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma.
    Karahan N; Güney M; Baspinar S; Oral B; Kapucuoglu N; Mungan T
    Eur J Gynaecol Oncol; 2007; 28(3):184-8. PubMed ID: 17624083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.